Genetix Biotherapeutics at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Genetix Biotherapeutics exhibits at Booth 3653 at ASH 2026 in New Orleans. Genetix Biotherapeutics supports a symposium on the changing treatment landscape for sickle cell disease. Written as a guide for hematologists, it spans gene therapies, activators and other new options.
| Organization | ASH 2026 Attendance |
|---|---|
Genetix Biotherapeutics Somerville, MA | |
Privately held company with FDA-approved gene therapies for sickle cell disease, beta-thalassemia and cerebral adrenoleukodystrophy. | Booth Exhibiting at Booth 3653 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 7:00am–10:00am A Hematologist’s Guide to the Sickle Cell Disease Revolution: Genes, Activators, and Beyond Approved and emerging gene therapies and new pyruvate kinase activators for sickle cell disease, and how to match patients to each and refer them. |
Instantly find 20 buyers from Genetix Biotherapeutics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction